ISIS PHARMACEUTICALS INC
Industry: Life Sciences ・ $ISIS on Nasdaq
Insider Sale
+$104,437
-4.23%
Shares
Shares Volume: 2,106 Shares
Average Share Price: $49.59
INSIDER
Schneider Eugene
EVP, Chf Clinical Develop Ofcr (Officer)
reported on Sep 4 2024
traded on Feb 2 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 47,659 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $439,607.97 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 6 |
| PURCHASES/SALES 1Y | 0 / 52 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $549,139.31 |
| COMPANY PREVIOUS TRADES |